• Je něco špatně v tomto záznamu ?

Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort

Z. Vegh, J. Burisch, N. Pedersen, I. Kaimakliotis, D. Duricova, M. Bortlik, S. Avnstrøm, KK. Vinding, J. Olsen, KR. Nielsen, KH. Katsanos, EV. Tsianos, L. Lakatos, D. Schwartz, S. Odes, G. Lupinacci, A. De Padova, L. Jonaitis, L. Kupcinskas, S....

. 2014 ; 8 (11) : 1506-15. [pub] 20140704

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem, validační studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc15031968

BACKGROUND AND AIMS: The aim of the present study was to validate the IBD (inflammatory bowel diseases) incidence reported in the 2010 ECCO-EpiCom (European Crohn's and Colitis Organization-Epidemiological Committee) inception cohort by including a second independent inception cohort from participating centers in 2011 and an Australian center to investigate whether there is a difference in the incidence of IBD between Eastern and Western European countries and Australia. METHODS: Fourteen centers from 5 Eastern and 9 Western European countries and one center from Australia participated in the ECCO-EpiCom 2011 inception cohort. Patients' data regarding disease type, socio-demographic factors, extraintestinal manifestations and therapy were entered into the Web-based EpiCom database, www.ecco-epicom.eu. RESULTS: A total of 711 adult patients were diagnosed during the inclusion year 2011, 178 (25%) from Eastern, 461 (65%) from Western Europe and 72 (10%) from Australia; 259 (37%) patients were diagnosed with Crohn's disease, 380 (53%) with ulcerative colitis and 72 (10%) with IBD unclassified. The mean annual incidence rate for IBD was 11.3/100,000 in Eastern Europe, 14.0/100,000 in Western Europe and 30.3/100,000 in Australia. Significantly more patients were diagnosed with complicated disease at diagnosis in Eastern Europe compared to Western Europe (43% vs. 27%, p=0.02). CONCLUSION: Incidence rates, disease phenotype and initial treatment characteristics in the 2011 ECCO-EpiCom cohort were not significantly different from that reported in the 2010 cohort.

1st Department of Medicine Semmelweis University Budapest Hungary

1st Division of Internal Medicine and Division of Gastroenterology Faculty of Medicine University of Ioannina Ioannina Greece

Clinic of Gastroenterology University of Medicine 'Victor Babes' Timisoara Romania

Department of Gastroenterology and Hepatology Soroka Medical Centre and Ben Gurion University of the Negev Beer Sheva Israel

Department of Gastroenterology Hospital de São João Porto Portugal

Department of Gastroenterology St Vincent's Hospital Melbourne Victoria Australia

Department of Gastroenterology State University of Medicine and Pharmacy Chisinau Republic of Moldova

Department of Medical Gastroenterology Gentofte Hospital Copenhagen Denmark

Department of Medicine Amager Hospital Amager Denmark

Department of Paediatric Gastroenterology Centre of Mother and Child Chisinau Republic of Moldova

Department of Pharmacology and Therapeutics Oporto Medical School Porto Portugal

Digestive Disease Centre Medical Section Herlev University Hospital Copenhagen Denmark

Gastroenterology Department Complexo Hospitalario Universitario de Vigo Vigo Spain

Gastroenterology Department POVISA Hospital Vigo Spain

Hospital de Vale de Sousa Porto Portugal

IBD Centre ISCARE Charles University Prague Czech Republic

Institute for Digestive Research Lithuanian University of Health Sciences Kaunas Lithuania

Medical Department The National Hospital of the Faroe Islands Torshavn Faroe Islands

MedInUP Centre for Drug Discovery and Innovative Medicines University of Porto Porto Portugal

Nicosia Private Practice Cyprus

On behalf of the EpiCom Northern Italy centre based in Crema Cremona Firenze Forlì and Padova and Reggio Emilia Italy

U O Gastroenterologia ed Endoscopia Digestiva University of Ioannina Forlì Italy

U O Gastroenterologia ed Endoscopia Ospedale Maggiore di Crema Crema Italy

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15031968
003      
CZ-PrNML
005      
20151013110852.0
007      
ta
008      
151005s2014 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.crohns.2014.06.004 $2 doi
035    __
$a (PubMed)24998983
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Vegh, Z $u Digestive Disease Centre, Medical Section, Herlev University Hospital, Copenhagen, Denmark; 1st Department of Medicine, Semmelweis University, Budapest, Hungary. Electronic address: veghzsuzsi@gmail.com.
245    10
$a Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort / $c Z. Vegh, J. Burisch, N. Pedersen, I. Kaimakliotis, D. Duricova, M. Bortlik, S. Avnstrøm, KK. Vinding, J. Olsen, KR. Nielsen, KH. Katsanos, EV. Tsianos, L. Lakatos, D. Schwartz, S. Odes, G. Lupinacci, A. De Padova, L. Jonaitis, L. Kupcinskas, S. Turcan, O. Tighineanu, I. Mihu, LF. Barros, F. Magro, D. Lazar, A. Goldis, A. Fernandez, V. Hernandez, O. Niewiadomski, S. Bell, E. Langholz, P. Munkholm, PL. Lakatos, . ,
520    9_
$a BACKGROUND AND AIMS: The aim of the present study was to validate the IBD (inflammatory bowel diseases) incidence reported in the 2010 ECCO-EpiCom (European Crohn's and Colitis Organization-Epidemiological Committee) inception cohort by including a second independent inception cohort from participating centers in 2011 and an Australian center to investigate whether there is a difference in the incidence of IBD between Eastern and Western European countries and Australia. METHODS: Fourteen centers from 5 Eastern and 9 Western European countries and one center from Australia participated in the ECCO-EpiCom 2011 inception cohort. Patients' data regarding disease type, socio-demographic factors, extraintestinal manifestations and therapy were entered into the Web-based EpiCom database, www.ecco-epicom.eu. RESULTS: A total of 711 adult patients were diagnosed during the inclusion year 2011, 178 (25%) from Eastern, 461 (65%) from Western Europe and 72 (10%) from Australia; 259 (37%) patients were diagnosed with Crohn's disease, 380 (53%) with ulcerative colitis and 72 (10%) with IBD unclassified. The mean annual incidence rate for IBD was 11.3/100,000 in Eastern Europe, 14.0/100,000 in Western Europe and 30.3/100,000 in Australia. Significantly more patients were diagnosed with complicated disease at diagnosis in Eastern Europe compared to Western Europe (43% vs. 27%, p=0.02). CONCLUSION: Incidence rates, disease phenotype and initial treatment characteristics in the 2011 ECCO-EpiCom cohort were not significantly different from that reported in the 2010 cohort.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a antiflogistika nesteroidní $x terapeutické užití $7 D000894
650    _2
$a kohortové studie $7 D015331
650    _2
$a ulcerózní kolitida $x komplikace $x diagnóza $x farmakoterapie $x epidemiologie $7 D003093
650    _2
$a kolonoskopie $x využití $7 D003113
650    _2
$a stenóza $x etiologie $7 D003251
650    _2
$a Crohnova nemoc $x komplikace $x diagnóza $x farmakoterapie $x epidemiologie $7 D003424
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a imunosupresiva $x terapeutické užití $7 D007166
650    _2
$a incidence $7 D015994
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mesalamin $x terapeutické užití $7 D019804
650    _2
$a lidé středního věku $7 D008875
650    _2
$a stupeň závažnosti nemoci $7 D012720
650    _2
$a kouření $x epidemiologie $7 D012907
650    _2
$a steroidy $x terapeutické užití $7 D013256
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Austrálie $x epidemiologie $7 D001315
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a validační studie $7 D023361
700    1_
$a Burisch, J $u Digestive Disease Centre, Medical Section, Herlev University Hospital, Copenhagen, Denmark.
700    1_
$a Pedersen, N $u Digestive Disease Centre, Medical Section, Herlev University Hospital, Copenhagen, Denmark.
700    1_
$a Kaimakliotis, I $u Nicosia Private Practice, Cyprus.
700    1_
$a Duricova, D $u IBD Centre ISCARE, Charles University, Prague, Czech Republic.
700    1_
$a Bortlik, M $u IBD Centre ISCARE, Charles University, Prague, Czech Republic.
700    1_
$a Avnstrøm, S $u Department of Medicine, Amager Hospital, Amager, Denmark. $7 gn_A_00010376
700    1_
$a Vinding, K Kofod $u Department of Medicine, Amager Hospital, Amager, Denmark.
700    1_
$a Olsen, J $u Medical Department, The National Hospital of the Faroe Islands, Torshavn, Faroe Islands.
700    1_
$a Nielsen, K R $u Medical Department, The National Hospital of the Faroe Islands, Torshavn, Faroe Islands.
700    1_
$a Katsanos, K H $u 1st Division of Internal Medicine and Division of Gastroenterology, Faculty of Medicine, University of Ioannina, Ioannina, Greece.
700    1_
$a Tsianos, E V $u 1st Division of Internal Medicine and Division of Gastroenterology, Faculty of Medicine, University of Ioannina, Ioannina, Greece.
700    1_
$a Lakatos, L $u 1st Department of Medicine, Semmelweis University, Budapest, Hungary.
700    1_
$a Schwartz, D $u Department of Gastroenterology and Hepatology, Soroka Medical Centre and Ben-Gurion University of the Negev, Beer Sheva, Israel.
700    1_
$a Odes, S $u Department of Gastroenterology and Hepatology, Soroka Medical Centre and Ben-Gurion University of the Negev, Beer Sheva, Israel.
700    1_
$a Lupinacci, G $u U.O.Gastroenterologia ed Endoscopia, Ospedale Maggiore di Crema, Crema, Italy; On behalf of the EpiCom Northern Italy centre based in Crema, Cremona, Firenze, Forlì & Padova and Reggio Emilia, Italy.
700    1_
$a De Padova, A $u On behalf of the EpiCom Northern Italy centre based in Crema, Cremona, Firenze, Forlì & Padova and Reggio Emilia, Italy; U.O. Gastroenterologia ed Endoscopia Digestiva, University of Ioannina, Forlì, Italy.
700    1_
$a Jonaitis, L $u Institute for Digestive Research, Lithuanian University of Health Sciences, Kaunas, Lithuania.
700    1_
$a Kupcinskas, L $u Institute for Digestive Research, Lithuanian University of Health Sciences, Kaunas, Lithuania.
700    1_
$a Turcan, S $u Department of Gastroenterology, State University of Medicine and Pharmacy, Chisinau, Republic of Moldova.
700    1_
$a Tighineanu, O $u Department of Paediatric Gastroenterology, Centre of Mother and Child, Chisinau, Republic of Moldova.
700    1_
$a Mihu, I $u Department of Paediatric Gastroenterology, Centre of Mother and Child, Chisinau, Republic of Moldova.
700    1_
$a Barros, L F $u Hospital de Vale de Sousa, Porto, Portugal.
700    1_
$a Magro, F $u Department of Gastroenterology, Hospital de São João, Porto, Portugal; Department of Pharmacology and Therapeutics, Oporto Medical School, Porto, Portugal; MedInUP-Centre for Drug Discovery and Innovative Medicines, University of Porto, Porto, Portugal.
700    1_
$a Lazar, D $u Clinic of Gastroenterology, University of Medicine 'Victor Babes', Timisoara, Romania.
700    1_
$a Goldis, A $u Clinic of Gastroenterology, University of Medicine 'Victor Babes', Timisoara, Romania.
700    1_
$a Fernandez, A $u Gastroenterology Department, POVISA Hospital, Vigo, Spain.
700    1_
$a Hernandez, V $u Gastroenterology Department, Complexo Hospitalario Universitario de Vigo, Vigo, Spain.
700    1_
$a Niewiadomski, O $u Department of Gastroenterology, St Vincent's Hospital, Melbourne, Victoria, Australia.
700    1_
$a Bell, S $u Department of Gastroenterology, St Vincent's Hospital, Melbourne, Victoria, Australia.
700    1_
$a Langholz, E $u Department of Medical Gastroenterology, Gentofte Hospital, Copenhagen, Denmark.
700    1_
$a Munkholm, P $u Digestive Disease Centre, Medical Section, Herlev University Hospital, Copenhagen, Denmark.
700    1_
$a Lakatos, P L $u 1st Department of Medicine, Semmelweis University, Budapest, Hungary.
700    1_
$a ,
773    0_
$w MED00166945 $t Journal of Crohn's & colitis $x 1876-4479 $g Roč. 8, č. 11 (2014), s. 1506-15
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24998983 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20151005 $b ABA008
991    __
$a 20151013111041 $b ABA008
999    __
$a ok $b bmc $g 1092844 $s 915094
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 8 $c 11 $d 1506-15 $e 20140704 $i 1876-4479 $m Journal of Crohn's and colitis $n J Crohns Colitis $x MED00166945
LZP    __
$a Pubmed-20151005

Najít záznam

Citační ukazatele

Možnosti archivace